Abstract Antibody-drug conjugates (ADCs) are potential therapeutics combining two molecules linked together: an antibody that provides targeting to specific cells, and a warhead drug that can deconjugate from the antibody and kill those cells. The warhead drug by itself would be too nonspecific; the antibody by itself would be insufficiently effective at killing the cells.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Inez
Contact Inez, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack